Table 1.
Demographic and clinical data.
| Stroke patients (n = 42) | Healthy control (n = 55) | t/χ2 | p | |
|---|---|---|---|---|
| Gender, male | 21 (50.0) | 29 (52.7) | 0.071 | 0.790 |
| Age, years | 57.86 ± 11.17 | 56.73 ± 10.21 | 0.518 | 0.605 |
| Educational level, years | 10.74 ± 3.39 | 11.00 ± 3.82 | -0.351 | 0.727 |
| High risk factor | ||||
| Hypertension | 25 (59.5) | 29 (52.7) | 0.446 | 0.504 |
| Diabetes | 11 (26.2) | 12 (21.8) | 0.252 | 0.616 |
| Hyperlipidemia | 12 (28.6) | 16 (29.1) | 0.003 | 0.955 |
| Atrial fibrillation | 2 (2.1) | 1(1.8) | 0.689 | 0.407 |
| MMSE | 28.07 ± 1.28 | 28.15 ± 1.27 | -0.284 | 0.777 |
| Illness duration, days | 14.29 ± 2.14 | - | ||
| Stroke type | ||||
| Ischemia | 40 (95.2) | - | ||
| Hemorrhage | 2 (4.8) | - | ||
| Location of lesion | ||||
| Coronal radiate | 15 (35.7) | - | ||
| Internal capsule | 15 (35.7) | - | ||
| Basel ganglia | 10 (23.8) | - | ||
| Thalamus | 2 (4.8) | - | ||
| Lesion volume, cc3 | 6.10 ± 8.55 | - | ||
| NIHSS | 5.86 ± 4.14 | - | ||
| FMA-total | 76.45 ± 14.12 | - | ||
| IVT use | 4 (9.5) | - | ||
Data represent n (%) or mean ± SD. MMSE, the Mini-Mental State Examination; NIHSS, the National Institutes of Health Stroke Scale; FMA-total, Fugl-Meyer assessment for upper and lower extremities; IVT, intravenous thrombolysis.